πŸ‡ΊπŸ‡Έ FDA
Patent

US 8114900

Amorphous carvedilol dihydrogen phosphate

granted A61PA61P9/00A61P9/12

Quick answer

US patent 8114900 (Amorphous carvedilol dihydrogen phosphate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P9/00, A61P9/12